New Oral Direct-Acting Antiviral Agents for Treatment of Chronic Hepatitis-C Infection in Patients With Chronic Kidney Disease Including Dialysis Patients and Kidney Transplant Recipients

SM Journal of Nephrology and Therapeutics
doi 10.36876/smjnt.1007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

JSMCentral LLC

Related search

Treating Hepatitis C Viral Infection in Patients With Chronic Kidney Disease: When and How

Clinical Liver Disease
Hepatology
2017English

Treatment of the Chronic Hepatitis C Complicated by Mixed Cryoglobulinemia With Direct-Acting Antiviral Agents

Jurnal Infektologii
Infectious Diseases
2018English

Management of the Kidney Transplant Patient With Chronic Hepatitis C Infection

International Journal of Nephrology
Nephrology
2011English

Oral Manifestation and Caries Experience in Pre-Dialysis Chronic Kidney Disease Patients

Archives of Orofacial Sciences
Oral SurgeryOrthodontics
2019English

Letter: Chronic Kidney Disease Risk in Patients With Chronic Hepatitis B

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Prevalence of Hepatitis B and Hepatitis C in Patients of Chronic Kidney Disease

International Journal of Research in Medical Sciences
2019English

The Real-World Efficacy and Safety of Direct-Acting Oral Antiviral Treatment in Chronic Hepatitis C Genotype 1 Patients in Turkey

Cumhuriyet Medical Journal
Medicine
2018English

Generic Sofosbuvir-Based Interferon-Free Direct Acting Antiviral Agents for Patients With Chronic Hepatitis C Virus Infection: A Real-World Multicenter Observational Study

Scientific Reports
Multidisciplinary
2018English

Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy